Cargando…

Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair

Prostaglandins are important mediators of bone repair, and cyclooxygenases are required for prostaglandin production. Data from animal studies suggest that both non-specific and specific inhibitors of cyclooxygenases impair fracture healing but that this is due to the inhibition of COX-2 and not COX...

Descripción completa

Detalles Bibliográficos
Autor principal: Einhorn, Thomas A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154427/
https://www.ncbi.nlm.nih.gov/pubmed/12716441
http://dx.doi.org/10.1186/ar607
_version_ 1782120748424364032
author Einhorn, Thomas A
author_facet Einhorn, Thomas A
author_sort Einhorn, Thomas A
collection PubMed
description Prostaglandins are important mediators of bone repair, and cyclooxygenases are required for prostaglandin production. Data from animal studies suggest that both non-specific and specific inhibitors of cyclooxygenases impair fracture healing but that this is due to the inhibition of COX-2 and not COX-1. Although these data raise concerns about the use of COX-2-specific inhibitors as anti-inflammatory or anti-analgesic drugs in patients undergoing bone repair, clinical reports have been inconclusive. Because animal data suggest that the effects of COX-2 inhibitors are both dose-dependent and reversible, in the absence of scientifically sound clinical evidence it is suggested that physicians consider short-term administration or other drugs in the management of these patients.
format Text
id pubmed-154427
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1544272003-05-07 Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair Einhorn, Thomas A Arthritis Res Ther Commentary Prostaglandins are important mediators of bone repair, and cyclooxygenases are required for prostaglandin production. Data from animal studies suggest that both non-specific and specific inhibitors of cyclooxygenases impair fracture healing but that this is due to the inhibition of COX-2 and not COX-1. Although these data raise concerns about the use of COX-2-specific inhibitors as anti-inflammatory or anti-analgesic drugs in patients undergoing bone repair, clinical reports have been inconclusive. Because animal data suggest that the effects of COX-2 inhibitors are both dose-dependent and reversible, in the absence of scientifically sound clinical evidence it is suggested that physicians consider short-term administration or other drugs in the management of these patients. BioMed Central 2003 2002-10-21 /pmc/articles/PMC154427/ /pubmed/12716441 http://dx.doi.org/10.1186/ar607 Text en Copyright © 2003 BioMed Central Ltd
spellingShingle Commentary
Einhorn, Thomas A
Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair
title Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair
title_full Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair
title_fullStr Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair
title_full_unstemmed Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair
title_short Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair
title_sort cox-2: where are we in 2003? - the role of cyclooxygenase-2 in bone repair
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154427/
https://www.ncbi.nlm.nih.gov/pubmed/12716441
http://dx.doi.org/10.1186/ar607
work_keys_str_mv AT einhornthomasa cox2wherearewein2003theroleofcyclooxygenase2inbonerepair